How We're Crushing It in Health's Biggest Opportunity

Hey, it's Arik.

I want to talk about what might be the biggest opportunity in the health and wellness space right now: peptides.

We've been doing email and SMS marketing for a few peptide companies, but avoided Meta ads due to their strict regulations. One wrong move can get your entire ad account banned. And when you're managing multiple clients, that's a risk most aren't willing to take. In fact, we stayed in our lane for a while, until recently.

I felt in my core that we couldn’t let this opportunity slip away, and the potential was too enormous to ignore. So, we made the call, and we did it with our eyes wide open.

And what happened next proved what I suspected: with the right strategy, it works.


Why Peptides Are the Next Big Thing
Before I dive into the numbers, let me give you some context. Peptides are being quoted by industry experts as potentially becoming as big as vitamins or other common supplements. We're talking about a market opportunity that could reshape the entire health and wellness industry.

Now, obviously, there’s still a ton of research to be done, and I’m not pretending otherwise. But the consumer appetite is undeniable. Think about it: we're at the ground floor of what could become a massive industry.


How We Launched Paid Ads (Without Getting Banned)
Meta has very clear guidelines when it comes to advertising anything remotely related to health. For peptides, the rules are even tighter.

You can’t make medical claims, you can’t promise results, and you can’t even infer outcomes in most cases.

So here’s what we did:
‣ Built a brand-forward ad strategy that focused on education instead of claims.
‣ Created landing pages that kept all language within Meta's advertising guidelines.
‣ Prepped a new ad account before we launched, just in case the original got flagged.

And guess what? It did.

Toward the end of November, the original ad account was flagged. But lucky for us, we had a second one ready to go, we switched within hours and kept the momentum.

Performance stayed strong, conversions didn’t slow down, and we didn’t lose ground during one of the most critical buying windows of the year.


The Results:
I can't mention the brand name since I'm sharing real numbers, but the results speak for themselves.

November 14-24 Performance:

Total Spend: $834.07
Revenue Tracked: $11,427.71
ROAS: 13.70x
Purchases: 40
Cost Per Acquisition: $20.85
Average Order Value: $285.69

That's a 13.70x return on ad spend. In the peptide space. On Meta. Let that sink in.

Consistent Performance Across Multiple Periods:

Nov 3-9: 15.03x ROAS ($1,630 spend, $24,505 revenue)
Oct 28-Nov 3: 9.35x ROAS ($1,507 spend, $14,094 revenue)
Oct 21-27: 9.11x ROAS ($1,472 spend, $13,398 revenue)

Take a look at November alone:

12.21x ROAS ($2,680.50 spend, $32,729.43 revenue)

Even as we scaled spend and tested different approaches, we maintained nearly double-digit ROAS across multiple periods.


Email: Driving Consistent Revenue Through the Funnel
While Meta ads were driving awareness and new customers, email marketing was the real revenue driver.

October Email Performance:

November Email Performance:

So, What’s the Takeaway?
We’re not saying every peptide brand should launch Meta ads tomorrow. If you’re not ready to navigate the compliance landscape, don’t touch it.

But if you’ve got:
‣ The right brand foundation
‣ A strong email engine already converting
‣ A team that knows how to speak to customers while staying compliant

Then yeah, the opportunity is real.

And if you’re in supplements, wellness, or adjacent spaces with similar ad policy challenges, the same logic applies. Build your email list, test creative thoroughly, stay within policy, and move fast when things break.

This space is only heating up.

What This Means for Your Business
Even if you're not in the peptide space, there are valuable lessons here:

1. Regulated Industries Can Be Goldmines
The more regulated an industry is, the fewer competitors you'll face. If you can navigate the compliance requirements, you can dominate.

2. Work Within the System
Don't try to push boundaries or find loopholes. Build your strategy around compliance from day one.

3. High-Value Customers
As you can see from our AOV numbers ($285+ average), peptide customers tend to be higher-value and more committed to their purchases. Focus on attracting the right audience, not just any audience.

4. Prepare for Setbacks
Have backup plans, multiple accounts, and diversified strategies. Setbacks are part of the game in regulated industries.

5. Partner with Experts
This isn't a DIY situation. Work with agencies and consultants who understand the regulatory landscape.


The Bottom Line
The peptide market is challenging, it's risky, but for brands and agencies willing to do the work, the rewards can be extraordinary.

We've proven that it's possible to achieve incredible results while staying compliant. The key is having the right strategy, the right messaging, and the right risk management approach.

See you next Thursday,
Arik